NO308506B1 - Anvendelse av grønn porfyrin (Gp)-forbindelse for fremstilling av et fotokjemisk medikament - Google Patents
Anvendelse av grønn porfyrin (Gp)-forbindelse for fremstilling av et fotokjemisk medikamentInfo
- Publication number
- NO308506B1 NO308506B1 NO944537A NO944537A NO308506B1 NO 308506 B1 NO308506 B1 NO 308506B1 NO 944537 A NO944537 A NO 944537A NO 944537 A NO944537 A NO 944537A NO 308506 B1 NO308506 B1 NO 308506B1
- Authority
- NO
- Norway
- Prior art keywords
- photochemical
- drug
- compound
- preparation
- green porphyrin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/889,707 US5776966A (en) | 1992-05-27 | 1992-05-27 | Selective cell inactivation in blood |
PCT/CA1993/000215 WO1993024127A1 (en) | 1992-05-27 | 1993-05-27 | Selective cell inactivation in blood |
Publications (3)
Publication Number | Publication Date |
---|---|
NO944537D0 NO944537D0 (no) | 1994-11-25 |
NO944537L NO944537L (no) | 1995-01-20 |
NO308506B1 true NO308506B1 (no) | 2000-09-25 |
Family
ID=25395640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944537A NO308506B1 (no) | 1992-05-27 | 1994-11-25 | Anvendelse av grønn porfyrin (Gp)-forbindelse for fremstilling av et fotokjemisk medikament |
Country Status (23)
Country | Link |
---|---|
US (1) | US5776966A (ja) |
EP (1) | EP0642342B1 (ja) |
JP (1) | JP3174821B2 (ja) |
KR (1) | KR950701522A (ja) |
AT (1) | ATE194491T1 (ja) |
AU (1) | AU687734B2 (ja) |
CA (1) | CA2136447C (ja) |
CZ (1) | CZ283846B6 (ja) |
DE (1) | DE69329026T2 (ja) |
DK (1) | DK0642342T3 (ja) |
ES (1) | ES2147754T3 (ja) |
FI (1) | FI945586A (ja) |
GR (1) | GR3034529T3 (ja) |
HU (1) | HUT78021A (ja) |
IL (1) | IL105815A (ja) |
MX (1) | MX9303127A (ja) |
NO (1) | NO308506B1 (ja) |
NZ (1) | NZ252085A (ja) |
PT (1) | PT642342E (ja) |
SK (1) | SK143994A3 (ja) |
TW (1) | TW257674B (ja) |
WO (1) | WO1993024127A1 (ja) |
ZA (1) | ZA933723B (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807881A (en) * | 1992-05-27 | 1998-09-15 | Quadra Logic Technologies, Inc. | Method for selectively reducing activated leukocyte cell population |
US5756541A (en) | 1996-03-11 | 1998-05-26 | Qlt Phototherapeutics Inc | Vision through photodynamic therapy of the eye |
CA2221912A1 (en) * | 1997-11-21 | 1999-05-21 | David Dolphin | Photosensitizers with improved biodistribution and light-absorbing properties |
US6117862A (en) * | 1998-10-09 | 2000-09-12 | Qlt, Inc. | Model and method for angiogenesis inhibition |
US6602274B1 (en) | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
US7022843B1 (en) | 1999-04-14 | 2006-04-04 | The University Of British Columbia | β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
US6734192B1 (en) | 1999-08-23 | 2004-05-11 | Mp-1 Inc. | Treatment of viral infections |
US7541184B2 (en) | 2000-02-24 | 2009-06-02 | Invitrogen Corporation | Activation and expansion of cells |
US7572631B2 (en) | 2000-02-24 | 2009-08-11 | Invitrogen Corporation | Activation and expansion of T cells |
WO2002064163A2 (en) | 2001-02-15 | 2002-08-22 | Qlt Inc. | Reduction or prevention of pdt related inflammation |
WO2002100326A2 (en) | 2001-05-01 | 2002-12-19 | The General Hospital Corporation | Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies |
JP2005502618A (ja) * | 2001-06-04 | 2005-01-27 | ザ・ジェネラル・ホスピタル・コーポレイション | 光力学的化合物を用いて脆弱なプラークを検出および治療する方法 |
US20040175373A1 (en) * | 2002-06-28 | 2004-09-09 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
AU2003253684A1 (en) * | 2002-06-28 | 2004-01-19 | Xcyte Therapies, Inc. | Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
US20050084967A1 (en) * | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
US7659301B2 (en) * | 2003-04-15 | 2010-02-09 | The General Hospital Corporation | Methods and devices for epithelial protection during photodynamic therapy |
US7220778B2 (en) * | 2003-04-15 | 2007-05-22 | The General Hospital Corporation | Methods and devices for epithelial protection during photodynamic therapy |
KR100604350B1 (ko) | 2004-07-15 | 2006-07-25 | 학교법인 인제학원 | 광역학 치료용 광민감성 물질로 유용한 사이클릭테트라피롤 고분자와 이의 제조방법 |
EP2164418B1 (en) | 2007-06-27 | 2014-01-08 | The General Hospital Corporation | Apparatus for optical inhibition of photodynamic therapy |
US10328085B2 (en) | 2014-05-09 | 2019-06-25 | Uniwersytet Jagiellonski | Cobalt porphyrins for the treatment of blood-related disorders |
PL233504B1 (pl) | 2014-05-09 | 2019-10-31 | Univ Jagiellonski | Protoporfiryna IX kobaltu do stosowania w leczeniu neutropenii i białaczek |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610241A (en) * | 1984-07-03 | 1986-09-09 | Gordon Robert T | Atherosclerosis treatment method |
US5011684A (en) | 1985-09-05 | 1991-04-30 | Beth Israel Hospital Association | Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance |
US5171749A (en) * | 1987-01-20 | 1992-12-15 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US5095030A (en) * | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
DE3821254A1 (de) | 1988-06-23 | 1990-01-04 | Hoffmann Elektrokohle | Schleifstueck fuer stromabnehmer sowie verfahren zu seiner herstellung |
US5190966A (en) * | 1988-07-06 | 1993-03-02 | Health Research, Inc. | Purified hematoporphyrin dimers and trimers useful in photodynamic therapy |
US5028594A (en) * | 1988-12-27 | 1991-07-02 | Naxcor | Use of photodynamic compositions for cytotoxic effects |
US4960408A (en) * | 1989-01-10 | 1990-10-02 | Klainer Albert S | Treatment methods and vaccines for stimulating an immunological response against retroviruses |
US5149708A (en) * | 1989-06-07 | 1992-09-22 | University Of British Columbia | Photosensitizing Diels-Alder porphyrin derivatives |
US5087636A (en) * | 1990-02-20 | 1992-02-11 | University Of British Columbia | Method to destroy malignant cells in mononuclear cell populations |
US5214036A (en) * | 1990-03-08 | 1993-05-25 | University Of British Columbia | Benzoporphyrin derivatives for photodynamic therapy |
-
1992
- 1992-05-27 US US07/889,707 patent/US5776966A/en not_active Expired - Fee Related
-
1993
- 1993-05-17 KR KR1019940704290A patent/KR950701522A/ko not_active Application Discontinuation
- 1993-05-27 ZA ZA933723A patent/ZA933723B/xx unknown
- 1993-05-27 DK DK93909729T patent/DK0642342T3/da active
- 1993-05-27 AU AU40571/93A patent/AU687734B2/en not_active Ceased
- 1993-05-27 WO PCT/CA1993/000215 patent/WO1993024127A1/en active IP Right Grant
- 1993-05-27 CZ CZ942918A patent/CZ283846B6/cs unknown
- 1993-05-27 PT PT93909729T patent/PT642342E/pt unknown
- 1993-05-27 JP JP50004594A patent/JP3174821B2/ja not_active Expired - Fee Related
- 1993-05-27 HU HU9403385A patent/HUT78021A/hu unknown
- 1993-05-27 DE DE69329026T patent/DE69329026T2/de not_active Expired - Fee Related
- 1993-05-27 MX MX9303127A patent/MX9303127A/es unknown
- 1993-05-27 EP EP93909729A patent/EP0642342B1/en not_active Expired - Lifetime
- 1993-05-27 CA CA002136447A patent/CA2136447C/en not_active Expired - Fee Related
- 1993-05-27 NZ NZ252085A patent/NZ252085A/en unknown
- 1993-05-27 IL IL10581593A patent/IL105815A/xx not_active IP Right Cessation
- 1993-05-27 AT AT93909729T patent/ATE194491T1/de not_active IP Right Cessation
- 1993-05-27 ES ES93909729T patent/ES2147754T3/es not_active Expired - Lifetime
- 1993-05-27 SK SK1439-94A patent/SK143994A3/sk unknown
- 1993-06-08 TW TW082104553A patent/TW257674B/zh active
-
1994
- 1994-11-25 NO NO944537A patent/NO308506B1/no not_active IP Right Cessation
- 1994-11-28 FI FI945586A patent/FI945586A/fi unknown
-
2000
- 2000-09-29 GR GR20000402219T patent/GR3034529T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2147754T3 (es) | 2000-10-01 |
ATE194491T1 (de) | 2000-07-15 |
TW257674B (ja) | 1995-09-21 |
ZA933723B (en) | 1993-12-15 |
GR3034529T3 (en) | 2000-12-29 |
HU9403385D0 (en) | 1995-02-28 |
CA2136447A1 (en) | 1993-12-09 |
DE69329026D1 (de) | 2000-08-17 |
EP0642342A1 (en) | 1995-03-15 |
FI945586A0 (fi) | 1994-11-28 |
NO944537D0 (no) | 1994-11-25 |
JPH08501278A (ja) | 1996-02-13 |
CA2136447C (en) | 2001-06-19 |
IL105815A0 (en) | 1993-09-22 |
FI945586A (fi) | 1995-01-27 |
DK0642342T3 (da) | 2000-10-09 |
AU687734B2 (en) | 1998-03-05 |
NZ252085A (en) | 1998-02-26 |
JP3174821B2 (ja) | 2001-06-11 |
CZ291894A3 (en) | 1995-09-13 |
CZ283846B6 (cs) | 1998-06-17 |
KR950701522A (ko) | 1995-04-28 |
EP0642342B1 (en) | 2000-07-12 |
IL105815A (en) | 2000-01-31 |
US5776966A (en) | 1998-07-07 |
DE69329026T2 (de) | 2001-03-22 |
MX9303127A (es) | 1994-06-30 |
PT642342E (pt) | 2000-11-30 |
NO944537L (no) | 1995-01-20 |
SK143994A3 (en) | 1996-07-03 |
AU4057193A (en) | 1993-12-30 |
WO1993024127A1 (en) | 1993-12-09 |
HUT78021A (hu) | 1999-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308506B1 (no) | Anvendelse av grønn porfyrin (Gp)-forbindelse for fremstilling av et fotokjemisk medikament | |
NZ292854A (en) | Use of an photoactive compound to treat multiple sclerosis which is followed by light therapy | |
EP0333606A3 (en) | Preparation of t-cell and t-cell membrane for use in prevention and treatment of autoimmune diseases | |
DE59205846D1 (de) | Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems | |
ES2022886B3 (es) | Conjunto de dispositivos luminosos para un sistema de tratamiento de pacientes por fotoactivacion. | |
AU6951087A (en) | Pump block for interfacing irradiation chamber to photoactivation patient treatment system | |
IL126366A0 (en) | Photopheresis treatment of leukocytes | |
EP0295280A4 (en) | Use of protoporphyrin and stannic mesoporphyrin for the manufacture of a medicament for the treatment of psoriasis. | |
ATE80616T1 (de) | Prostaglandin e1-derivate und ihre therapeutische anwendung. | |
ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. | |
AU6950487A (en) | Irradiation chamber for photoactivation patient treatment system | |
ES2169033T3 (es) | Empleo de la manganeso-superoxidodismutasa (mn-sod) para la elaboracion de medicamentos para el tratamiento de enfermedades, en una dosis pequeña. | |
DK0499679T3 (da) | Terapeutisk middel til diabetisk gangræn | |
SU1080280A1 (ru) | Способ лечени онкологических больных | |
ATE247468T1 (de) | Kombinationstherapie von topoisomerase ii toxinen und bis-dioxypiperazinderivaten | |
Muller et al. | THE EFFECT OF PORPHYRIN PHOTOSENSITIZERS ON THE TOXICITY OF l, 3‐BIS (2‐CHLOROETHYL)‐1‐NITROSOUREA IN C57BL/6J MICE | |
ES2011526A6 (es) | Instalacion para la regeneracion y depouracion de la sangre. | |
SU1807595A1 (ru) | Средство для лечения отравлений ртутью | |
RU94045639A (ru) | Способ лечения инсулинозависимого сахарного диабета тяжелой формы течения | |
RU2002104683A (ru) | Способ лечения миокардитов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2003 |